H5N1 SPOTREP #3

October 22, 2024  /  TLP:CLEAR

Healthcare Ready is MONITORING for this event. We are monitoring potential concerns for supply chain disruptions and impacts on healthcare services on our Alert Hub.

Contents

• Situation Overview and Key Updates
• Treatments, Vaccines, and Testing

Situation Overview and Key Updates

• As of October 21, according to the CDC, there have been 27 reported cases of H5N1 this year. Of those 27 cases, 16 have been confirmed as H5N1.
  • In California, 13 cases were reported as exposure to cattle.
  • In Colorado, one case was reported as exposure to cattle and nine were reported as exposure to poultry.
  • In Michigan, two cases were reported as exposure to cattle.
  • In Texas, one case was reported as exposure to cattle.
  • In Missouri, one case was reported as unknown exposure which is concerning however people who were in close proximity to that individual were not infected.
• Additionally, on October 21, four poultry workers in Washington tested positive for H5N1. Samples were sent to the CDC for analysis and final confirmation.
• As of October 22, there have been 48 states with outbreaks in poultry and 14 states with outbreaks in cattle.
  • The Animal and Plant Health Inspection Service (APHIS) developed a map that shows the number of HPAI confirmed cases in livestock herds around the US. That map can be found here.
• CDC continues to state that the immediate risk to the general public for H5N1 is low, however the risk for people with exposure to infected animals remains high.

Treatments, Vaccines, and Testing

• As part of a CDC initiative, more than 100,000 doses of seasonal influenza vaccines will be allocated to 12 states where cattle have tested positive for H5N1. Those doses are allocated specifically for farm workers to prevent the spread of influenza in their respective communities.
• The CDC is collaborating with pharmacy networks (eTrueNorth and Walgreens) to provide free testing of symptomatic individuals in California to increase testing for seasonal flu and H5N1 testing if needed.
• ASPR’s Biomedical Advanced Research and Development Authority (BARDA) has taken action to bolster the US preparedness against H5N1 by granting $72 million to CSL Seqirus, Sanofi, and GSK to complete the next steps in influenza A(H5) vaccine manufacturing.

FOLLOW US

Sign up to receive event-specific emails for your state or states where your organization operates

 For media inquiries please reach out to Alexis Wing at news@healthcareready.org.

Healthcare Ready leverages unique relationships with government, nonprofit and medical supply chains to build and enhance the resiliency of communities before, during and after disasters.  

Healthcare Ready is approved by the Internal Revenue Service as a 501 (C)(3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Healthcare Ready's Federal Identification Number (EIN) is 46-3134601.